NCT00230503
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
Not specified
Clinical trial condition
Hepadnaviridae Infections
Explore clinical trials studying Hepadnaviridae Infections. Study availability and eligibility vary by location and protocol.
1,149 public trials
113 recruiting studies
Hepadnaviridae Infections trial results
NCT01623778
- Conditions
- Adverse Effects, Australia Antigen Positive, Blood-Borne Infections, +10 more
- Locations
-
- Changhai hospital Shanghai, Shanghai Municipality, China
NCT00169728
- Conditions
- Actinomycetales Infections, Allogeneic Haematopoietic Stem Cell Transplantation, Bacterial Infections, +35 more
- Locations
-
- University Childrens Hospital Berlin, Germany
- University Children Hospital Düsseldorf, Germany
- University Children Hospital Erlangen, Germany
- University Children Hospital Frankfurt, Germany
NCT00347009
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +17 more
- Locations
-
- GSK Investigational Site Pokfulam, Hong Kong
- GSK Investigational Site Singapore
- GSK Investigational Site Daegu, South Korea
- GSK Investigational Site Pusan, South Korea
NCT00395018
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Tulane University Hospital & Clinic New Orleans, Louisiana, United States
- Mayo Clinic Rochester, Minnesota, United States
- University Of Nebraska Medical Center Omaha, Nebraska, United States
Completed
Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B
NCT00095121
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
- Boston, Massachusetts, United States
NCT00625560
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Pusan National University School of Medicine Busan, South Korea
- Severance Hospital Seoul, South Korea
Completed
Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA
NCT00625339
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Pusan National University School of Medicine Busan, South Korea
- Severance Hospital Seoul, South Korea
NCT01203319
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
Not specified
NCT00371150
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
- Locations
-
- Alabama Liver & Digestive Specialists (Alds) Montgomery, Alabama, United States
- University Of Arizona Tucson, Arizona, United States
- George Washington University Medical Center Washington D.C., District of Columbia, United States
- University Of Miami Miami, Florida, United States